PTC Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. META
5. TSLA
6. ISRG
7. SMCI
8. RTX
9. GOOGL
10. S

Go back to PTC Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update

PTC Therapeutics (PTCT) Misses Q3 EPS by 22c

November 2, 2017 5:03 PM EDT

PTC Therapeutics (NASDAQ: PTCT) reported Q3 EPS of ($0.82), $0.22 worse than the analyst estimate of ($0.60). Revenue for the quarter came in at $41.85 million versus the consensus estimate of $45.03 million.

2017 Guidance:

Translarna net sales guidance for 2017 is anticipated to be between $120 and $140 million. We... More